Pancreatic Cancer Research

ResearcherChinese University of Hong KongActive in the last 2 years

Raymond S. Y. Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2433-8036; OpenAlex author ID A5040750924. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 trial · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma. Co-author DOI 10.12809/hkmj2210476↗
  2. Risks and impacts of thromboembolism in patients with pancreatic cancer. Co-author DOI 10.12809/hkmj219788↗
  3. Pancreatic cysts suspected to be branch duct intraductal papillary mucinous neoplasm without concerning features have low risk for development of pancreatic ca… Co-author PMID 26423829↗

Trials 1

  1. Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features Principal investigator NCT05334836↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Lam Chan · 2 shared papers, 2023–2024 · strength 0.39
  2. Francis P. T. Mok · 1 shared paper, 2024 · strength 0.20
  3. Ksh Chok · 1 shared paper, 2024 · strength 0.20
  4. Chi‐Leung Chiang · 1 shared paper, 2024 · strength 0.20
  5. Landon Long Chan · 1 shared paper, 2023 · strength 0.19
  6. Robert D. Lawson · 1 shared paper, 2015 · strength 0.05
  7. Thomas J. Savides · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.